Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Takeda Ventures, Inc.

Status
ACTIVE
Global HQ
Palo Alto, United States
Countries of investment
  • USA
  • Asia Pacific
  • USA
Investment stages
  • Pre-Seed
Industries
  • Fintech
  • Health Tech
  • AI
  • Blockchain
  • Cryptocurrency
About
Takeda Pharmaceutical Company Limited is a global, patient-focused, R&D-driven biopharmaceutical company engaged in the research, development, manufacture, marketing, and commercialization of pharmaceutical products both in Japan and internationally.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

Takeda Ventures focuses on highcaliber, therapeutic, platformbased companies around the world. It specifically invests in early stage, preclinical opportunities and products which complement Takeda’s pipeline with the mission to create strategic growth opportunities for Takeda through building, managing, and investing in innovative companies.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in private equity, the fund manager has successfully executed over 20 deals, primarily targeting the technology and healthcare sectors across North America and Europe. Backed by a data-driven investment approach, the manager emphasizes a thematic focus on innovative solutions that address market gaps. Notable exits include several high-profile transactions that significantly enhanced portfolio value. Their strategic style combines operational expertise with rigorous analytics, ensuring robust value creation at each investment stage.

Takeda Ventures, Inc. Contacts Information

Secondary contact

Team

Yoko Sugimoto

Mary Wirth

Hanna Vasiliuk

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp